Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
73.5 mg/m³
Most sensitive endpoint:
repeated dose toxicity
DNEL related information
Overall assessment factor (AF):
6
Modified dose descriptor starting point:
NOAEC
Acute/short term exposure
Hazard assessment conclusion:
no-threshold effect and/or no dose-response information available
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no-threshold effect and/or no dose-response information available
Acute/short term exposure
Hazard assessment conclusion:
no-threshold effect and/or no dose-response information available
DNEL related information

Workers - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
416.6 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
DNEL related information
Overall assessment factor (AF):
24
Modified dose descriptor starting point:
NOAEL
Acute/short term exposure
Hazard assessment conclusion:
no-threshold effect and/or no dose-response information available
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no-threshold effect and/or no dose-response information available
Acute/short term exposure
Hazard assessment conclusion:
no-threshold effect and/or no dose-response information available

Workers - Hazard for the eyes

Additional information - workers

DNEL acute

A DNELacuteshould be established for substances if an acute hazard toxicity (leading to C&L) has been identified and a potential for high peak exposures exists.

DL-Alpha-Tocopheryl acetate does not have to be labelled for acute toxicity and therefore, a derivation of a DNELacute is not necessary.

DNEL long-term systemic

DL-Alpha-Tocopheryl acetate is not classified for any toxicological endpoint. For the DNEL-derivation a NOAEL of 500 mg/kg bw was used derived from the 90-day repeated dose oral, based on hemorrhagic diathesis in males and females (an increase in APTT, PT and fibrinogen at 2000 mg/kg).

The dermal DNEL for long-term exposure - systemic effects for workers is derived as follows:

Description

Value

Remark

Step 1) Relevant dose-descriptor

NOAEL: 500 mg/kg bw/day

Based on hemorrhagic diathesis in males and females

Step 2) Modification of starting point

 

x100/5

 

 

100% for oral absorption, and 5% absorption is assumed for dermal absorption

Modified dose-descriptor

500 x 100/5 = 10000 mg/kg bw/day

Step 3) Assessment factors

 

 

Interspecies

4

 

Allometric scaling for the rat, the additional factor of 2.5 is omitted.

Intraspecies

3*

Default assessment factor

Exposure duration

2

A correction for duration from sub-chronic to chronic is required

Dose response

1

 

Quality of database

1

 

DNEL

Value

*DNEL using ECETOC AF

 10000/ (4 x 3 x 2 x 1 x 1)= 416.6 mg/kg bw/day

The inhalation DNEL for long-term exposure - systemic effects for workers is derived as follows:

Description

Value

Remark

Step 1) Relevant dose-descriptor

NOAEL: 500 mg/kg bw/day

Based on hemorrhagic diathesis in males and females

Step 2) Modification of starting point

/0.38 m3/kg bw

  

 x 6.7 m3/10 m3

 

 

 

 

x50/100

 

8 h respiratory volume for rat.

 

Correction for activity driven differences of respiratory volumes in workers compared to workers in rest.

 

 

Default 50% for oral absorption, and 100% absorption is assumed for inhalation.

Modified dose-descriptor

500 x 0.67 x 0.5 / 0.38 = 440 mg/m3

Step 3) Assessment factors

 

 

Interspecies

1.0

 

No allometric scaling has to be applied in case of oral to inhalation route to route extrapolation. The additional factor of 2.5 is omitted.

Intraspecies

3*

Default assessment factor

Exposure duration

2

A correction for duration from sub-chronic to chronic is required

Dose response

1

 

Quality of database

1

 

DNEL

Value

 *DNEL using ECETOC AF

 440/ (1.0 x 3 x 2 x 1 x 1)= 73.5 mg/m3

General Population - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
21.7 mg/m³
Most sensitive endpoint:
repeated dose toxicity
DNEL related information
Overall assessment factor (AF):
10
Acute/short term exposure
Hazard assessment conclusion:
no-threshold effect and/or no dose-response information available
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no-threshold effect and/or no dose-response information available
Acute/short term exposure
Hazard assessment conclusion:
no-threshold effect and/or no dose-response information available
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
250 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
DNEL related information
Overall assessment factor (AF):
40
Modified dose descriptor starting point:
NOAEL
Acute/short term exposure
Hazard assessment conclusion:
no-threshold effect and/or no dose-response information available
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no-threshold effect and/or no dose-response information available
Acute/short term exposure
Hazard assessment conclusion:
no-threshold effect and/or no dose-response information available

General Population - Hazard via oral route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
12.5 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
DNEL related information
Overall assessment factor (AF):
40
Modified dose descriptor starting point:
NOAEL
Acute/short term exposure
Hazard assessment conclusion:
no-threshold effect and/or no dose-response information available
DNEL related information

General Population - Hazard for the eyes

Additional information - General Population

DNEL acute

A DNELacuteshould be established for substances if an acute hazard toxicity (leading to C&L) has been identified and a potential for high peak exposures exists.

DL-Alpha-Tocopheryl acetate

does not have to be labelled for acute toxicity and therefore, a derivation of a DNELacuteis not necessary.

DNEL long-term systemic

Vitamin acetate (isomer) is not classified for any toxicological endpoint.

For the DNEL-derivation a NOAEL of 500 mg/kg bw was used derived from the 90-day repeated dose oral, based on hemorrhagic diathesis in males and females (an increase in APTT, PT and fibrinogen at 2000 mg/kg).

The dermal DNEL for long-term exposure - systemic effects for general population is derived as follows:

Description

Value

Remark

Step 1) Relevant dose-descriptor

NOAEL: 500 mg/kg bw/day

Based on hemorrhagic diathesis

Step 2) Modification of starting point

 

x100/5

 

 

100% for oral absorption and 5% absorption is assumed for dermal absorption.

Modified dose-descriptor

500 x 100/5 = 10000 mg/kg bw/day

Step 3) Assessment factors

 

 

Interspecies

4

 

Allometric scaling for the rat, the additional factor of 2.5 is omitted.

Intraspecies

5*

Default assessment factor

Exposure duration

2

A correction for duration from sub-chronic to chronic is required

Dose response

1

 

Quality of database

1

 

DNEL

Value

 *DNEL using ECETOC AF

10000/ (4 x 5 x 2 x 1 x 1)= 250 mg/kg bw/day

The inhalation DNEL for long-term exposure - systemic effects for general population is derived as follows:

Description

Value

Remark

Step 1) Relevant dose-descriptor

NOAEL: 500 mg/kg bw/day

Based on hemorrhagic diathesis

Step 2) Modification of starting point

/ 1.15 m3/kg bw

 

 

x 50/100

 

24 h respiratory volume for rats.

 

 

50% for oral absorption and 100% absorption is assumed for inhalation.

Modified dose-descriptor

500 / 1.15 x 0.5 = 217 mg/m3

Step 3) Assessment factors

 

 

Interspecies

1.0

 

No allometric scaling has to be applied in case of oral to inhalation route to route extrapolation. The additional factor of 2.5 is omitted.

Intraspecies

5*

Default assessment factor

Exposure duration

2

A correction for duration from sub-chronic to chronic is required.

Dose response

1

 

Quality of database

1

 

DNEL

Value

*DNEL using ECETOC AF

217/ (1.0 x 5 x 2 x 1 x 1)= 21.7 mg/m3

The oral DNEL for long-term exposure - systemic effects for general public is derived as follows:

Description

Value

Remark

Step 1) Relevant dose-descriptor

NOAEL: 500 mg/kg bw/day

Based on hemorrhagic diathesis

Step 2) Modification of starting point

Not required

 

 

 

 

 

Step 3) Assessment factors

 

 

Interspecies

4

 

Allometric scaling for the rat, the additional factor of 2.5 is omitted.

Intraspecies

5*

Default assessment factor

Exposure duration

2

A correction for duration from sub-chronic to chronic is required

Dose response

1

 

Quality of database

1

 

DNEL

Value

*DNEL using ECETOC AF

500/ (4 x 5 x 2 x 1 x 1)= 12.5 mg/kg bw/day